Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3
Abstract Background TRIP13 is highly expressed in several cancers and is closely connected with cancer progression. However, its roles on the growth and metastasis of hepatocellular carcinoma (HCC), and the underlying mechanism are still unclear. Methods Combining bioinformatics with previous studie...
Main Authors: | Jianning Yao, Xuexiu Zhang, Jiaheng Li, Dongyao Zhao, Bing Gao, Haining Zhou, Shilin Gao, Lianfeng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0704-y |
Similar Items
-
TGF-β/Smad Signaling in Growth Control of Prostate Epithelial Cells
by: Yang, Jiayi
Published: (2009) -
YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts
by: Zhaoping Qin, et al.
Published: (2018-04-01) -
Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
by: Feng Xie, et al.
Published: (2014-10-01) -
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
by: Ester Gonzalez-Sanchez, et al.
Published: (2021-06-01) -
Roles of TGFβ signaling Smads in squamous cell carcinoma
by: Han Gangwen, et al.
Published: (2011-12-01)